Manufacturing News and Research

RSS
FDA issues Complete Response Letter to Alexza’s ADASUVE NDA

FDA issues Complete Response Letter to Alexza’s ADASUVE NDA

Emergent BioSolutions first quarter total revenues increase to $50.3M

Emergent BioSolutions first quarter total revenues increase to $50.3M

Lexicon first quarter revenues decrease 50% to $0.3 million

Lexicon first quarter revenues decrease 50% to $0.3 million

CSI third quarter revenues increase 5% to $21.2 million

CSI third quarter revenues increase 5% to $21.2 million

STAAR Surgical first quarter total revenue increases 4% to $15.5M

STAAR Surgical first quarter total revenue increases 4% to $15.5M

XenoPort first quarter revenues increase to $10.4 million

XenoPort first quarter revenues increase to $10.4 million

Xcellerex introduces XDUO Quad single-use mixing system for biomanufacturing

Xcellerex introduces XDUO Quad single-use mixing system for biomanufacturing

AtriCure first quarter revenue increases 11.8% to $17.5 million

AtriCure first quarter revenue increases 11.8% to $17.5 million

ArthroCare first quarter total revenue increases 5.6% to $92.9 million

ArthroCare first quarter total revenue increases 5.6% to $92.9 million

Novo Nordisk granted exclusive rights to Caisson's heparosan-based drug delivery technology

Novo Nordisk granted exclusive rights to Caisson's heparosan-based drug delivery technology

Biogen Idec first quarter revenues increase 7% to $1.3 billion

Biogen Idec first quarter revenues increase 7% to $1.3 billion

Nelson-Miller announces acquisition of KDM

Nelson-Miller announces acquisition of KDM

Almac acquires high-speed blister line for new Audubon packaging facility

Almac acquires high-speed blister line for new Audubon packaging facility

Teleflex launches Hudson RCI Softech Plus to help clinicians

Teleflex launches Hudson RCI Softech Plus to help clinicians

FDA approves Protalix, Pfizer’s ELELYSO for treatment of type 1 Gaucher disease

FDA approves Protalix, Pfizer’s ELELYSO for treatment of type 1 Gaucher disease

Exact Sciences first quarter net loss increases to $10.6 million

Exact Sciences first quarter net loss increases to $10.6 million

IDEX announces acquisition of ERC

IDEX announces acquisition of ERC

Hologic second quarter revenues increase 7.4% to $471.2 million

Hologic second quarter revenues increase 7.4% to $471.2 million

Kauffman Foundation sponsors National Conference on Value-driven Engineering

Kauffman Foundation sponsors National Conference on Value-driven Engineering

Australian Government must take the lead in tackling antibiotic resistance: NPS Board Chair Dr Janette Randall address to the National Press Club

Australian Government must take the lead in tackling antibiotic resistance: NPS Board Chair Dr Janette Randall address to the National Press Club

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.